Comment on Haidar et al. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes. Diabetes Care 2023;46:1372-1378

Diabetes Care. 2023 Oct 1;46(10):e207-e208. doi: 10.2337/dc23-1243.

Authors

Julie Blervaque¹, Sandrine Lablanche¹, Hector Romero-Ugalde², Alice Adenis², Guillaume Charpentier³, Pierre Yves Benhamou¹

Affiliations

¹ Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, Grenoble, France.
² Diabeloop SA, Grenoble, France.
³ CERITD (Center for Study and Research for Improvement of the Treatment of Diabetes), Bioparc-Genopole Evry-Corbeil, Evry, France.

No abstract available

Publication types

Randomized Controlled Trial
Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carbohydrates
Cross-Over Studies
Diabetes Mellitus, Type 1* / drug therapy
Humans
Insulin / therapeutic use
Insulin, Regular, Human
Pancreas, Artificial*

Substances

Insulin
Insulin, Regular, Human
Carbohydrates